Lunar adds volume imaging to Artoscan

Article

Competing with Magna-Labin the niche MRI segment is Lunar, which markets the Artoscanmagnet manufactured by Esaote Biomedica of Italy. Artoscan isa 0.2-tesla permanent magnet scanner optimized for extremity imaging. Lunar, of Madison, WI, will release

Competing with Magna-Labin the niche MRI segment is Lunar, which markets the Artoscanmagnet manufactured by Esaote Biomedica of Italy. Artoscan isa 0.2-tesla permanent magnet scanner optimized for extremity imaging.

Lunar, of Madison, WI, will release a new software packageat the RSNA meeting called Version 3.3 B. The package includes3-D imaging sequences and multiformat reconstruction and givesArtoscan the ability to conduct volume imaging, according to BillConn, MRI marketing manager.

Lunar is also introducing a remote diagnostics capability forthe scanner, dubbed Artoscan Remote Assistance System (ARAS).ARAS allows Lunar engineers to maintain, diagnose and providesoftware upgrades for Artoscan via modem.

Artoscan was cleared for marketing by the Food and Drug Administrationlate last year (SCAN 11/3/93). Lunar has sold 60 units worldwideand eight in the U.S., Conn said. The company expects have a U.S.installed base of 10 to 12 units by the end of the year.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.